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Abstract
Air pollution is increasingly recognized as an important and modifiable determinant of cardiovascular
diseases in urban communities. The potential detrimental effects are both acute and chronic having a
strong impact on morbidity and mortality. The acute exposure to pollutants has been linked to adverse
cardiovascular events such as myocardial infarction, heart failure and life-threatening arrhythmias. The
long-terms effects are related to the lifetime risk of death from cardiac causes. The WHO estimates that
air pollution is responsible for 3 million premature deaths each year. The evidence supporting these data
is very strong nonetheless, epidemiologic and observational data have the main limitation of imprecise
measurements. Moreover, the lack of clinical experimental models makes it difficult to demonstrate the
individual risk. The other limitation is related to the lack of a clear mechanism explaining the effects of
pollution on cardiovascular mortality. In the present review we will explore the epidemiological, clinical
and experimental evidence of the effects of ozone on cardiovascular diseases.
The pathophysiologic consequences of air pollutant exposures have been extensively investigated in
pulmonary systems, and it is clear that some of the major components of air pollution (e.g. ozone and
particulate matter) can initiate and exacerbate lung disease in humans [1]. It is possible that pulmonary
oxidant stress mediated by particulate matter and/or ozone (O3) exposure can result in downstream
perturbations in the cardiovasculature, as the pulmonary and cardiovascular systems are intricately
associated, and it is well documented that specific environmental toxins (such as tobacco smoke [2])
introduced through the lungs can initiate and/or accelerate cardiovascular disease development. Indeed,
several epidemiologic studies have proved that there is an association between PM and O3 and the
increased incidence of cardiovascular morbidity and mortality [3]. Most of the evidence comes from
studies of ambient particles concentrations. However, in Europe and elsewhere, the air pollution profile
has gradually changed toward a more pronounced photochemical component. Ozone is one of the most
toxic components of the photochemical air pollution mixture. Indeed, the biological basis for these
observations has not been elucidated.
In the present review, the role of ozone as chemical molecule will be firstly considered. Secondly,
pathogenetic mechanisms connecting the atmospheric ozone level and cardiovascular pathology will be
examined. Thirdly, the literature relating hospitalization frequency, morbidity and mortality due to
cardiovascular causes and ozone concentration will be studied. The correlation between ozone level and
occurrence of acute myocardial infarction will be eventually discussed.
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Ozone is a molecule consisting of three oxygen atoms,
highly reactive and with a high oxidizing power. Ozone
reacts with biomolecules to form ozonides and free radi-
cals (figure 1). This reaction triggers an inflammatory
response that conveys increased systemic oxidative stress,
which has both pulmonary and cardiovascular effects. In
nature, considerable concentrations of ozone are found at
high altitude (15–60 Km high) within the so-called
"ozonosphere", where it forms a layer protecting the earth
from the sun's ultraviolet radiation.
On the other hand, in lower atmosphere layers, i.e. the so-
called "troposphere" (less than 15 km high from the
ground), ozone is naturally present at low concentrations,
due to natural interchange with the stratosphere. This
concentration, however, can rise in some area because of
the so-called "photochemical smog", originating in those
urban and suburban areas where other chemical pollut-
ants (nitrogen oxides, hydrocarbons and VOCs, volatile
organic compounds) combined with sun radiation might
induce ozone formation, especially during the summer.
Unlike "primary" pollutants, which are directly emitted
by specific sources, ozone is a "secondary" pollutant, so it
is difficult to determine the correlation with its precursors.
The sources of ozone precursor pollutants are both
anthropic (motor vehicles, combustion processes, ther-
moelectric plants, chemical solvents) and natural (woods
and forests emit highly reactive VOCs, like terpens). To
some extent, ozone is present in the troposphere because
of the natural interrange with the stratosphere, and its
concentration may vary between 20 and 80 μg/m3.
Higher concentrations of ozone are caused by photo-
chemical smog.
Ozone concentrations are also influenced by different
meteorological variables, such as sun radiation intensity
and temperature. Therefore the presence of ozone varies
during the day and different seasons. Ozone critical peak
period is summer, when particular conditions like high
pressure, low humidity, high temperature and scarce ven-
tilation facilitate pollutant stagnation and accumulation.
Moreover, high sun radiation triggers photochemical reac-
tions, which are responsible for ozone formation. Gener-
ally, maximum values are reached during the hottest time
of the day, from 12 to 6 pm, then decrease during night
hours (figure 2). On the other hand, the lowest concentra-
tions are recorded in winter, mainly because of the
reduced sun radiation.
NOAEL (No Observable Adverse Effect Level) and LOAEL
(Lowest Observed Adverse Effect Level) values have not
been set for ozone. This means that apparently there is no
threshold dose, below which no effects occur. To this end,
it is very helpful to refer to the values provided by WHO,
which sets an average value of 100–120 μg/m3 for the
protection of global population. Moreover, this value is in
line with the one set by Italian law.
If coordinates are to be defined for health protection, the
following values can be referred to:
110 μg/m3 average on 8 hours (180 μg/m3 average on 1
hour) as health protection limit for subjects with a high
sensitivity.
140 μg/m3 average on 8 hours (240 μg/m3 average on 1
hour) as health protection limit for subjects with a low
sensitivity.
More than 220 μg/m3 average on 8 hours (more than 360
μg/m3 average on 1 hour) as health protection limit for
the rest of the population.
Nonetheless, the remarkable influence of sporting activi-
ties on ozone potential effects must be taken into account:
if outdoor sports are practiced more frequently, effects
similar to the above mentioned ones can be observed,
Molecular structure of ozoneFigure 1
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110 μg/m3 average on 8 hours (180 μg/m3 average on 1
hour) as health protection limit.
Biological effects of ozone on the cardiovascular 
system
Further studies aiming to demonstrate the correlation
between the increased ozone concentration in air and car-
diovascular diseases have been carried out. In particular,
the effects on vascular tone, arterial pressure control, auto-
nomic control of heart rate and serum concentration of
inflammatory markers have been considered (Figure 3).
Vasoconstriction
Evidence that ozone can influence macrovascular diame-
ter and tone is found in a randomized, double-blind,
crossover chamber study [4], which was recently reported.
The study demonstrated that short term inhalation (2
hours) of both fine particulate air pollution (150 μg/m3)
and ozone (120 ppb) at urban environment levels were
associated with brachial artery narrowing. It is reasonable
to suspect that the coronary vasculature may respond sim-
ilarly to air pollution exposure because brachial and coro-
nary reactivity are correlated. A reduction in coronary
diameter of this relatively small magnitude (0.1 mm),
however, would have minimal impact on healthy adults.
Nonetheless, congruously with epidemiological findings
that individuals at increased risk for acute air pollution-
related cardiac events generally have pre-existing cardio-
vascular disease [5], this degree of sudden coronary vaso-
constriction could promote cardiac ischemia in people
with underlying flow-limiting obstructive lesions or could
trigger instability of susceptible plaques [6]. Furthermore,
the vasculature of patients with coronary risk factors is
known to hyper-react to a variety of vasoconstrictors [7,8],
which potentially increases their susceptibility for acute
cardiac events after air pollution exposure. Additional
investigations in coronary circulation and high-risk indi-
viduals are needed to confirm these hypotheses.
Systemic arterial hypertension
Zanobetti et al. [9] have shown that air pollution may
contribute to increased risk of cardiac morbidity and mor-
tality in patients with pre-existing cardiac diseases,
through increased peripheral blood pressure. In single
pollutant models adjusting for all other non-pollutant
factors but excluding PM2,5, higher resting diastolic
blood pressure was significantly associated with 120
hours averages of ozone (2,7% increase; 95% CI 0,02 to
5,4).
Potential biological mechanisms for the vasoconstriction
include a reflex increase in sympathetic nervous system
activity via stimulation of pulmonary vagal afferents or an
acute increase in vascular endothelin release, by direct
mechanisms or via activation of oxidative stress pathways
[4].
Autonomic control of heart rate and arrhythmias
Reduced heart rate variability (HRV) is a predictor of
increased risk for cardiovascular mortality and morbidity
[10,11]. HRV may be a marker for poor health or an etio-
logic factor, representing a disturbance of the autonomic
function, which increases the risk of cardiac events. Short-
term increases in particle air pollution have been associ-
ated with a rise in daily cardiovascular mortality and mor-
bidity in studies from cities throughout the industrialized
world [12].
In their work, Gold et al. suggest that both particulate and
O3 pollution may lead to short-term autonomic imbal-
ance, reflected by changes in heart rate and HRV.
Holguin et al. have observed that increased ozone and
fine particulate levels are especially related to a reduced
high-frequency component of heart rate variability, this
association being stronger in patients with arterial hyper-
tension.
Whether or not pollution-related short-term changes in
HRV or autonomic balance can partially account for asso-
ciations between particulate or O3 [13] levels and cardio-
vascular morbidity or mortality is unknown. Between-
person reduced HRV has been demonstrated to predict an
increased risk for subsequent cardiac events in a popula-
tion initially free of clinically apparent cardiac disease
[11], increased mortality in the elderly [10], and sustained
ventricular tachycardia [14]. In these between-person
comparisons, altered HRV may contribute to mortality
either as an etiologic factor or as a marker for poor health
and subclinical coronary artery disease. If altered HRV is
an etiologic factor for myocardial ischemia and fatal
O3 daily concentration redrawn from [40]Figure 2
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thetic predominance and/or diminished parasympathetic
tone.
An increase of air ozone levels has been also associated
with a rise in risks related to the sopraventricular arrhyth-
mia for the elderly [15].
Sarnat et al. observed odd ratio for having sopraventricu-
lar arrhythmia over the lenght of the protocol of 1,78%
for 14,9 ppb increases in air pollution for moving average
ozone concentration.
Inflammatory markers
Recent studies support that O3 exposure mediates an
inflammation response and increased oxidative stress in
the cardiovascular system.
In vitro studies in isolated peripheral human blood
mononuclear cells have shown that a significant relation-
ship exists between O3 and increased lipid peroxidation
and protein thiol group content [16]. Animal models also
show that O3 exposure causes increased systemic oxida-
tive stress [17].
Bocci et al. [18] have shown that ozone (O3) dissolved in
the water of either plasma, serum or physiological saline
generates reactive oxygen species (ROS), of which hydro-
gen peroxide (H2O2) can be unequivocally demon-
strated. Lipids present in plasma, preferentially those
present in lipoproteins, undergo peroxidation that is
somewhat O3-dose dependent and can be observed by
the measurement of thiobarbituric acid reactive sub-
stances. While the generation of H2O2 is crucial in acti-
vating both biochemical (hexose monophosphate shunt)
Cellular effects of O3Figure 3
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mechanisms, the role of lipid oxidation products (LOP)
remains to be investigated. In this study authors have also
shown that there is a small but considerable induction of
some cytokines (Tumor Necrosis Factor-alpha (TNF-a),
Interferon-gamma (INF-g) [19], and interleukin-2 (IL-2))
when human blood is directly exposed to O3 concentra-
tions up to 100 μg/ml per g of blood.
TNF-a is a cytokine involved in systemic inflammation
and is a member of a group of cytokines that stimulate the
acute phase reaction. Dysregulation and, in particular,
overproduction of TNF have been implicated in heart fail-
ure. TNF-a can induce an immediate myocardial dysfunc-
tion, and it has been demonstrated that, in vitro, it can
mitigate intra-cell flows of calcium ions [20].
IL-2 is a pro-inflammatory cytokine and its serum levels
are associated with carotid artery intima-media thickness,
a predictor of stroke and vascular disease.
Increased oxidant production can induce a spectrum of
cytokines and associated mediators that can diffuse into
the circulation and alter cardiac function. For example, in
another study it has been demonstrated that human
blood exposed to O3 leads to the release of other pro-
inflammatory cytokine IL-6, IL-8, and granulocyte-mono-
cyte colony-stimulating factor (GM-CSF) [21].
As far as pro-coagulant substances is concerned, Pekkenen
et al. [22] have found no significant association between
ozone levels and fibrinogen blood concentration.
Epidemiologic studies
In addition to its known pulmonary effects, O3 exposure
in humans has been associated with increased hospital
admissions related to cardiovascular complications, such
as acute myocardial infarction, coronary atherosclerosis
and pulmonary heart disease (figure 4). Early multicity
time-series studies of O3 and mortality have estimated a
broad range of effects; a 10 ppb increase in daily O3 was
associated with increases in daily mortality of 2.84%
(95% CI, 0.95–4.77%) for four European cities [23],
0.61% (95% CI, 0.38 to 1.60%) for seven Spanish cities
[24], 1.40% (95% CI, 0.68–2.12%) for six French cities
[25], and 0.43% (95% CI, 0.23–0.63%) for 80 US urban
centers from 1987 to 1994. A recent multi-site time series
study has provided strong evidence of an association
between mortality and short-term exposure to O3. In a
study that evaluated 95 communities within the U.S.,
there was a 0.52% (95% CI, 0.27–0.77%) increase in daily
mortality for a 10-ppb increase in O3 concentration of the
previous week. Moreover, these effects were still robust
after the adjustment for PM and temperature [26].
Another large study, which assessed the effects of O3
exposure on daily total and cause-specific mortality from
the 23 European cities, found that a 10 mg/m3 increase in
the 1-h O3 concentration was associated with a 0.45%
(95% CI, 0.17–0.52%) increase in the number of cardio-
vascular deaths, and the corresponding figures for the 8-h
ozone were similar [27]. The associations with total mor-
tality were independent of SO2 and particulate matter
with areodynamic diameter less than 10 microm (PM10)
but were somewhat confounded by NO2 and CO.
The association between daily variations in ozone and
cause-specific mortality is been also investigated by Gold-
berg et al. in a study conducted in Montreal. For an
increase in the 3-day running mean concentration of
ozone of 21,3 μg/m3, the percentage of increase in daily
deaths in the warm season is the following: non-acciden-
tal death, 3,3% (95% CI: 1.7, 5.0); cancer, 3.9% (95%
CI:1.0, 6.91); cardiovascular diseases, 2.5% (95% CI:0.2,
5.0); and respiratory diseases, 6.6% (95% CI: 1.8, 11.8).
These results were independent of the effects of other pol-
lutants and were consistent with a log-linear response
function. [28].
Table 1: Experimental setting
WHAT we have WHAT we need
Design Epidemiologic studies Clinical Studies
Endpoints Rate of disease occurrence Death for CV causes
Sample size Hundreds Tens
Parameter Population risk Individual risk assessment
O3 and mortalityFigure 4
O3 and mortality. Dose-response of ozone 1 hour (aver-
age of lags 0 and 1) and daily number of deaths during the 
summer season) redrawn from [27].Page 5 of 8
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pheric pollution as possible specific trigger of acute myo-
cardial infarction.
Ruidavets et al. [29] have conducted a study in which the
association between hospitalizations for myocardial infarc-
tion in south-western France (Toulouse) from 1997 to 1999
and the atmospheric concentrations of nitrogen oxide, sul-
phure and ozone oxide has been remarked, using the case-
crossover method. After correcting data according to temper-
ature and humidity variables, the relative risk of acute infarc-
tion occurrence was significantly related to a rise in ozone
concentration (median value of O3; 74.8 μg/m3) in the
same day and the day after the episode (for an ozone
increase of 5 μg/m3, the relative risk is 1,05 with p = 0,009
and 1,05 with p = 0,007, respectively). Instead, nitrogen and
sulphur oxides have shown no statistically significant associ-
ation. In Denver, which has a similar median level of O3
concentration (50.3 μg/m3), a 25th to 75th percentile
change of ozone increased the risk of hospitalization for AMI
and coronary atherosclerosis when the current day of O3
exposure and AMI admissions was considered [30]. In Barce-
lona (median value of O3 70.8 μg/m3), an increase of 100
μg/m3 of ozone air concentration was significantly associ-
ated (relative risk, 1.09) with increased cardiovascular mor-
tality in the elderly during the summer [31]. In Mexico City
(median O3 87.0 μg/m3), the mean concentration of O3
over a 2-day period was associated with a 1.8% increase in
cardiovascular mortality [32]. In Hong Kong and London,
with half the O3 concentration recorded in Toulouse
(median O3 28.3 and 32.0 μg/m3, respectively), associa-
tions between O3 exposure and cardiac admissions were less
consistent and remained uncertain [33]. Barnett et al. con-
ducted a study in 7 cities within New Zealand and Australia,
but no statistically significant correlation has been found
between hospitalizations for acute myocardial infarction
and ozone atmospheric levels.
Globally, the conflicting results could be due to the mul-
tiplicity of the studied health outcomes, the various types
and levels of pollution, and investigation methodologies.
Individual risks and experimental models: 
toward an environmental stress testing
As previously stated, one of the major problems related to
the assessment of ozone impact on the individual subject
is the need for a controlled experimental setting. The
major limitation of these epidemiologic studies is the lack
of adjustment for other major risk factors for CVD
(including smoking, lack of physical activity, poor diet,
and alcohol consumption). Another weakness of the
reviewed mortality studies is the difficulty of accurately
retrospectively assessing personal exposure. This remains
a scientific challenge. Previous reports have demonstrated
that the controlled exposure to ozone after a late airway
response elicited by allergen challenge can potentiate the
eosinophilic inflammatory response induced by the aller-
gen challenge itself in subjects with mild atopic asthma
[34]. This experimental setting may be theoretically trans-
ferred to assess the acute cardiovascular effects of ozone
controlled exposure. Hypothetically, it is possible to
design an environmental stress testing in which several
imaging and functional biomarkers of early atheroscle-
rotic damage are measured before and after a controlled
ozone exposure. The environmental challenge would
identify those patients at higher risk of developing overt
coronary artery disease (Table 1).
Conclusion
The revision of literature underlines the association
between ozone exposure and cardiovascular disease
occurrence. A broader and deeper knowledge, yet incom-
plete, on the ozone biological effects and possible
induced pathogenetic mechanisms supports the plausibil-
ity of this correlation. So far, mechanisms such as increase
of oxidative stress, activation of a considerable systemic
inflammatory response mediated by cytokines, modifica-
tion of endothelial function and vascular vasomotricity,
and alterations in autonomic control of cardiac frequency
have been observed and associated to atmospheric ozone
exposure.
In any case, it is commonly believed that biological effects
of atmospheric pollution cannot be attributed to a single
pollutant and it is not possible to classify some pollutants
as more harmful than others. It is the atmospheric com-
plex mix of different substances that, through common or
different processes, determine the above mentioned cardi-
ovascular effects. This statement helps understanding why
no experimental study has been able to reproduce the
environmental conditions, and why the results on the
harmful effects of air pollution may extremely vary, thus
influencing the correct scientific evaluation. For instance,
the highest concentrations of ozone, which is formed by
the effect of sun radiations on main pollutants (volatile
hydrocarbons, nitro compounds, carbon monoxide), can
be found at a considerable distance from pollution
sources.
In a wide revision of literature, Maitre et al. [35] estimate
that cardiovascular risk caused by atmospheric pollution
is equivalent to the one related to moderate obesity (body
mass index between 30 and 31,9 Kg/m2). Atmospheric
pollution is now a ubiquitous problem regarding millions
of people who are daily exposed. Therefore, even the
slighter increase of relative risk corresponds to a great
number of people who can show cardiovascular patho-
logic manifestations.Page 6 of 8
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ies is the individual susceptibility to the effects of environ-
mental pollutants, which remarkably varies among the
examined population. Genetic predisposition, mediated
by a different polymorphism of the genes involved in the
oxidative and inflammatory response, can play a major
role in influencing the effects of an interaction with
atmospheric pollutants.
It has been recently reported that a reduction in exposure
to ambient fine-particulate air pollution contributed to
significant and measurable improvements in life expect-
ancy in the United States [36]. Pope et al. noted that
although decreases in fine particulate air pollution
(PM2.5) could account for as much as 18% of the increase
in life expectancy of approximately 2.74 years occurring in
the United States between 1980 and 1999, other factors
may be partly responsible [36]. The effects of ambient air
pollution on population health can be addressed within
the broader context of risk assessment and management.
Population-health risk assessment involves the systematic
evaluation of genetic, environmental and social determi-
nants of health [37]. The evidence correlating pollution to
cardiovascular disease is strong and ascertained by epide-
miologic and clinical studies [38-40]. Primary and sec-
ondary prevention can be obtained only by reducing the
atmospheric pollution rate, a social priority to be listed in
the health policy agenda of the near future.
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